Pharmacokinetics of Vancomycin in the ICU in Renal Replacement Therapy

Withdrawn before enrolling

Conditions studied: Acute Kidney Injury

In brief

This study is an observational analysis that monitors the effect of different dialysis methods on vancomycin levels when patients are critically ill. No changes are made to therapy based on levels, but levels are checked more frequently than normal. The primary dialysis methods being studied are SLED (slow-low efficiency daily) dialysis and intermittent hemodialysis. Vancomycin is the only medication being evaluated in this study. This study will provide detailed information on how to dose vancomycin in patients that are on dialysis in the intensive care unit.

Key facts

Study ID

NCT00848809

Run by

Avera McKennan Hospital & University Health Center

People needed

0

Starts

2008-12-01

Expected to finish

2009-04-01

Last updated by the study team

2015-04-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• > 18 years of age
• One of the following types of dialysis modalities implemented:
• Slow-low efficiency daily dialysis Intermittent hemodialysis
• Use of study medication (vancomycin)

You may not qualify if…

• Inability to give informed consent

Where it is running

• Avera McKennan Hospital and University Health Center — Sioux Falls, South Dakota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.